BTG is set to make two acquisitions to create interventional medicine business. (Photo : Reuters)Medical bills are culprit of more than 60 percent of U.
Healthcare Health/Fitness
Novo AS Invests in Ophthotech Corporation
Novo AS invests in Ophhtotech Corporation for the further development of drug Fovista. In an announcement made today, Ophthotech Corporation said it was able to raise US$175 million in funding to finance the global Phase 3 clinical program of its lead medication Fovista.
ugichem GmbH Announces Eur2.25 Funding Round
ugichem GmbH announces it has raised Eur2.25 funding round. The developer of an original antisense drug system, ugichem GmbH, has announced that it has raised Eur2.
AstraZeneca Purchases Omthera Pharmaceuticals
AstraZeneca acquires Omthera's fish oil derived pharmaceutical line. In an announcement, AstraZeneca would be acquiring Omthera Pharmaceuticals for the price of US$443 million to boost its cardiovascular drug business.
Valeant Buys Bausch & Lomb
Valeant purchases Bausch & Lomb to create business unit that can generate US$3.5 billion in net revenue.
Latest News
Hospitals team with medical research facilities to protect themselves against higher costs (Photo : Reuters)Hospitals with improved medical care for elderly patients, and reduced deadly errors are estimated to get millions of dollars under an incentive program that aims to cut overall Medicare costs.
Royalty Pharma increases offer for Elan. Royalty Pharma has increased its offer to purchase Elan Corp by 12%. The new bid is now worth US$6. 4 billion, even after the Irish drugmaker has been making moves seeking to prevent the takeover bid and boost revenues for the company.
Actavis is set to purchase Warner-Chilcott for specific purposes. Actavis Inc, the generics pharmaceutical company, has announced its intention to purchase Warner Cholcott Plc, the specialty pharma company.
Alliance Boots and Walgreens cleared to invest in AmerisourceBergen. In an announcement today by Alliance Boots GmbH and Walgreens Company, it disclosed that they have received the necessary regulatory clearances for their equity investment in AmerisourceBergen Corporation, one of the biggest pharmaceutical companies in North America.
Elan purchases two new interests as well as plan for another buyback option to blunt the Royalty Pharma drug offer.
Amgen's cash flow, equity ratio and production phase would break out when all come together. The shares of Amgen has had a remarkable development since early 2013, surpassing the S&P 500 by 6%.
Bayer AG purchases Steigerwald for an undisclosed amount. The largest pharmaceutical firm in Germany, Bayer has announced it has agreed to purchase Steigerwald Arzneimittelwek GmbH, a privately owned maker of herbal medications.
Novartis, through its spokesperson, reiterates its statement that it is not interested in bidding for Actavis.
Kite Pharma secures US$20M and converts existing promissory notes into Series A preferred stock. Kite Pharma Inc. disclosed today in an announcement that it secured a US$20 million private placement of its Series A preferred stock.
